Overview
Heart failure is the leading cause of morbidity and mortality in the adult CHD population. Unlike acquired heart failure, CHD-related heart failure often involves unique anatomies — systemic right ventricles, Fontan circulations, and complex post-surgical physiology — that require specialized diagnostic and therapeutic approaches beyond standard heart failure guidelines.
CHD-Specific Heart Failure
Heart failure in CHD patients differs fundamentally from heart failure caused by coronary artery disease or cardiomyopathy. Patients with systemic right ventricles (e.g., post-atrial switch for transposition), single-ventricle physiology, or significant residual shunts develop failure through mechanisms that standard therapies may not address. Accurate phenotyping of the heart failure mechanism is the first step toward effective treatment.
Guideline-Directed Medical Therapy
While foundational heart failure medications (ACE inhibitors, beta-blockers, mineralocorticoid receptor antagonists, SGLT2 inhibitors) form the backbone of treatment, their application in CHD requires nuanced judgment. Dosing, drug selection, and monitoring intervals must account for the patient's specific anatomy, hemodynamics, and surgical history. We follow emerging ACHD-specific heart failure guidelines to optimize medical therapy.
Advanced Therapies
When medical therapy is insufficient, advanced options include cardiac resynchronization therapy, mechanical circulatory support (ventricular assist devices), and heart transplantation. The CHD population faces unique challenges in each of these domains — from device lead placement in abnormal venous anatomy to the need for specialized transplant centers experienced with complex re-operative surgery.
Monitoring & Prognosis
Structured heart failure monitoring includes serial biomarkers (BNP/NT-proBNP), cardiopulmonary exercise testing, advanced imaging, and symptom tracking. We use validated risk scores and longitudinal trend analysis to guide escalation decisions — ensuring patients receive the right intervention at the right time, not too early and not too late.
Who Is This For?
- Adults with CHD experiencing symptoms of heart failure (fatigue, edema, exercise intolerance)
- Patients with Fontan circulation or systemic right ventricle physiology
- CHD patients being evaluated for advanced therapies or transplant listing
- Providers seeking consultation on CHD-related heart failure management